Literature DB >> 10842879

Heterotopic ossification in total hip arthroplasty: the significance for clinical outcome.

S Eggli1, J Rodriguez, R Ganz.   

Abstract

This study evaluates 706 patients with 835 primary total hip replacements documented in a prospective fashion in a multicenter study with respect to correlation between heterotopic ossification (HO) and clinical outcome. Only patients without prophylaxis against HO entered the study. The mean clinical and radiological follow-up was 3.1 years (+/- 0.7). Heterotopic ossification was noted in 47% of all total hips replaced. It was graded as mild (Brooker I) in 29.1%, moderate (Brooker II) in 12.7%, and severe (Brooker III and IV) in 5.2%. All clinical parameters investigated were significantly affected with the increasing amount of heterotopic ossification. The strongest correlation was found in flexion range and spreading distance. Both factors were significantly decreased with higher degrees of ossification. The other clinical parameters investigated, walking capacity, limp, and use of analgesics, were altered to a lesser extent and only with higher degrees of heterotopic bone formation. Finally, patient satisfaction was significantly influenced by the degree of heterotopic ossification and dropped from almost 90% good or excellent patient satisfaction in the non-ossification group to less than 30% in the group with severe ossification.

Entities:  

Mesh:

Year:  2000        PMID: 10842879

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  10 in total

1.  Incidence of heterotopic ossification in direct anterior vs posterior approach to total hip arthroplasty: a retrospective radiographic review.

Authors:  Elizabeth A Newman; David C Holst; Daniel N Bracey; Gregory B Russell; Jason E Lang
Journal:  Int Orthop       Date:  2015-11-27       Impact factor: 3.075

2.  Classifications in brief: Brooker classification of heterotopic ossification after total hip arthroplasty.

Authors:  Kevin T Hug; Timothy B Alton; Albert O Gee
Journal:  Clin Orthop Relat Res       Date:  2014-11-27       Impact factor: 4.176

3.  Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.

Authors:  Sebastian Winkler; Hans-Robert Springorum; Tobias Vaitl; Martin Handel; Sabine Barta; Victoria Kehl; Benjamin Craiovan; Joachim Grifka
Journal:  Int Orthop       Date:  2016-01-04       Impact factor: 3.075

4.  Heterotopic ossification in primary total hip arthroplasty: risk factor analysis.

Authors:  Alessandro Aprato; Simone Cambursano; Stefano Artiaco; Stefano Bevilacqua; Paolo Catalani; Alessandro Massè
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-03-19

Review 5.  Animal models of typical heterotopic ossification.

Authors:  Lixin Kan; John A Kessler
Journal:  J Biomed Biotechnol       Date:  2010-10-19

6.  Extensive Surgical Wound Lavage Reduces the Incidence and Severity of Heterotopic Ossification in Primary Total Hip Replacement: A Study of 175 Hip Replacements.

Authors:  Avadhoot P Kantak; Nirav N Shah
Journal:  Hip Pelvis       Date:  2017-12-01

7.  Heterotopic Ossification in Orthopaedic and Trauma surgery: A Histopathological Ossification Score.

Authors:  M Ohlmeier; V Krenn; D M Thiesen; N A Sandiford; T Gehrke; M Citak
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

8.  Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty.

Authors:  Stella Oberberg; Jan Nottenkämper; Matthias Heukamp; Jan Krapp; Roland E Willburger
Journal:  J Orthop Surg Res       Date:  2021-02-27       Impact factor: 2.359

9.  Heterotopic ossification after total hip arthroplasty: When is development completed?

Authors:  Roland E Willburger; Friederike Brinkhoff; Jan Nottenkämper; Jan Krapp; Stella Oberberg
Journal:  J Orthop Surg Res       Date:  2022-03-05       Impact factor: 2.677

Review 10.  Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.

Authors:  Xi-Tian Zhu; Lei Chen; Jian-Hua Lin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.